The association of aldose reductase gene (AKR1B1) polymorphisms with diabetic neuropathy in adolescents

Diabetic Medicine

Volumn 22, Issue 10, 2005, Pages 1315-1320

  Donaghue, Kim C ^a,b   Margan, S H ^a   Chan, A K F ^a   Holloway, B ^a   Silink, M ^a,b   Rangel, T ^a   Bennetts, B ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Aldose reductase; Neuropathy; Pupillometry

Indexed keywords

ALDEHYDE REDUCTASE; CYTOSINE; GUANINE; MICROSATELLITE DNA; THYMINE;

ADOLESCENT; AKR1B1 GENE; ARTICLE; AUSTRALIA; CONFIDENCE INTERVAL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEAT ACCLIMATIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PUPIL REFLEX; PUPILLOMETRY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ALDEHYDE REDUCTASE; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PUPIL; REFLEX, PUPILLARY;

EID: 25844507450     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01631.x     Document Type: Article

References (30)

1. Hamada Y, Kitoh R, Raskin P. Crucial role of aldose reductase activity and plasma glucose level in sorbitol accumulation in erythrocytes from diabetic patients. Diabetes 1991; 40: 1233-1240.
2. Dent MT, Tebbs SE, Gonzalez AM, Ward JD, Wilson RM. Neutrophil aldose reductase activity and its association with established diabetic microvascular complications. Diabet Med 1991; 8: 439-442.
3. n dinucleotide repeat polymorphic marker at the 5′ end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients. Diabetes 1995; 44: 727-732.
4. Heesom AE, Hibberd ML, Millward A, Demaine AG. Polymorphism in the 5′-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes. Diabetes 1997; 46: 287-291.
5. Heesom AE, Millward A, Demaine AG. Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5′ end of the aldose reductase gene. J Neurol Neurosurg Psychiatry 1998; 64: 213-216.
6. Kao YL, Donaghue K, Chan A, Knight J, Silink M. A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes. Diabetes 1999; 48: 1338-1340.
7. Demaine A, Cross D, Millward A. Polymorphisms of the aldose reductase gene and susceptibility to retinopathy in type 1 diabtetes mellitus. Invest Opthamol Visual Sci 2000; 41: 4064-4068.
8. Liu YF, Wat NM, Chung SS, Ko BC, Lam KS. Diabetic nephropathy is associated with the 5′-end dinucleotide repeat polymorphism of the aldose reductase gene in Chinese subjects with Type 2 diabetes. Diabet Med 2002; 19: 113-118.
9. Li Q, Xie P, Huang J, Gu Y, Zeng W, Song H. Polymorphisms and functions of the aldose reductase gene 5′ regulatory region in Chinese patients with type 2 diabetes mellitus. Chinese Med J 2002; 115: 209-213.
10. Shah VO, Scavini M, Nikolic J, Sun Y, Vai S, Griffith JK et al. Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy. J Clin Endocrinol Metab 1998; 83: 2886-2891.
11. Yang B, Millward A, Demaine A. Functional differences between the susceptibility Z-2/C-106 and protective Z+2/T-106 promoter region polymorphisms of the aldose reductase gene may account for the association with diabetic microvascular complications. Biochimica Biophysica Acta 2003; 1639: 1-7.
12. Shah VO, Dorin RI, Sun Y, Braun M, Zager PG. Aldose reductase gene expression is increased in diabetic nephropathy. J Clin Endocrinol Metab 1997; 82: 2294-2298.
13. Hodgkinson AD, Bartlett T, Oates PJ, Millward BA, Demaine AG. The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes 2003; 52: 846-851.
14. Pfeifer MA, Schumer MP, Gelber DA. Aldose reductase inhibitors: the end of an era or the need for different trial designs? Diabetes 1997; 46: S82-S89.
15. Nakayama M, Nakamura J, Hamada Y, Chaya S, Mizubayashi R, Yasuda Y et al. Aldose reductase inhibition ameliorates pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy. Diabetes Care 2001; 24: 1093-1098.
16. Oates PJ. Polyol pathway and diabetic peripheral neuropathy. Int Rev Neurobiol 2002; 50: 325-392.
17. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003; 26: 1553-1579.
18. Pena MM, Donaghue KC, Fung AT, Bonney M, Schwingshandl J, Howard NJ, Silink M. The prospective assessment of autonomic nerve function by pupillometry in adolescents with type 1 diabetes mellitus. Diabet Med 1995; 12: 868-873.
19. Karachaliou F, Karavanaki K, Greenwood R, Baum JD. Consistency of pupillary abnormality in children and adolescents with diabetes. Diabet Med 1997; 14: 849-853.
20. Donaghue KC. Autonomic neuropathy: diagnosis and impact on health in adolescents with diabetes. Hormone Res 1998; 50: 33-37.
21. Karavanaki-Karanassiou K. Autonomic neuropathy in children and adolescents with diabetes mellitus. J Pediatric Endocrinol Metab 2001; 14: 1379-1386.
22. Pittasch D, Lobmann R, Behrens-Baumann W, Lehnert H. Pupil signs of sympathetic autonomic neuropathy in patients with type 1 diabetes. Diabetes Care 2002; 25: 1545-1550.
23. Schwingshandl J, Simpson JM, Donaghue K, Bonney MA, Howard NJ, Silink M. Pupillary abnormalities in type I diabetes occurring during adolescence. Comparisons with cardiovascular reflexes. Diabetes Care 1993; 16: 630-633.
24. Donaghue KC, Bonney M, Simpson JM, Schwingshandl J, Fung AT, Howard NJ, Silink M. Autonomie and peripheral nerve function in adolescents with and without diabetes. Diabet Med 1993; 10: 664-671.
25. Kao YL, Donaghue K, Chan A, Knight J, Silink M. An aldose reductase intragenic polymorphism associated with diabetic retinopathy. Diabetes Res Clin Prac 1999; 46: 155-160.
26. Ikegishi Y, Tawata M, Aida K, Onaya T. Z-4 allele upstream of the aldose reductase gene is associated with proliferative retinopathy in Japanese patients with NIDDM, and elevated luciferase gene transcription in vitro. Life Sci 1999; 65: 2061-2070.
27. Park HK, Ahn CW, Lee GT, Kim SJ, Song YD, Lim SK et al. (AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus. Diabetes Res Clin Prac 2002; 55: 151-157.
28. n dinucleotide repeat polymorphic marker at the 5′-region of the aldose reductase gene with retinopathy but not with nephropathy or neuropathy in Japanese patients with Type 2 diabetes mellitus. Diabet Med 1999; 16: 744-748.
29. Ng DP, Conn J, Chung SS, Larkins RG. Aldose reductase (AC)(n) microsatellite polymorphism and diabetic microvascular complications in Caucasian Type 1 diabetes mellitus. Diabetes Res Clin Prac 2001; 52: 21-27.
30. Hyllienmark L, Brismar T, Ludvigsson J. Subclinical nerve dysfunction in children and adolescents with IDDM. Diabetologia 1995; 38: 685-692.